The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions.
about
Protandim, a fundamentally new antioxidant approach in chemoprevention using mouse two-stage skin carcinogenesis as a modelSensitivity of Dendritic Cells to Microenvironment SignalsOncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cellsInflammasome activation of IL-1 family mediators in response to cutaneous photodamageGPER signalling in both cancer-associated fibroblasts and breast cancer cells mediates a feedforward IL1β/IL1R1 response.The tumor microenvironment in esophageal cancerInterleukin-1β Processing Is Dependent on a Calcium-mediated Interaction with CalmodulinPromotion of a cancer-like phenotype, through chronic exposure to inflammatory cytokines and hypoxia in a bronchial epithelial cell line modelFetal exposure to chlordane and permethrin mixtures in relation to inflammatory cytokines and birth outcomesEpidermal growth factor protects squamous cell carcinoma against cisplatin-induced cytotoxicity through increased interleukin-1β expressionTumor-derived interleukin-1 promotes lymphangiogenesis and lymph node metastasis through M2-type macrophagesSulforaphane inhibits prostaglandin E2 synthesis by suppressing microsomal prostaglandin E synthase 1.Identification of S100A8-correlated genes for prediction of disease progression in non-muscle invasive bladder cancerBacteria peptidoglycan promoted breast cancer cell invasiveness and adhesiveness by targeting toll-like receptor 2 in the cancer cellsExpression of interleukin-1 (IL-1) ligands system in the most common endometriosis-associated ovarian cancer subtypes.p38MAPK plays a crucial role in stromal-mediated tumorigenesisThe relationship between pro-inflammatory cytokines and pain, appetite and fatigue in patients with advanced cancer.Subcloning and characterization of highly metastatic cells derived from human esophageal squamous cell carcinoma KYSE150 cells by in vivo selection.Secreted interleukin-1alpha induces a metastatic phenotype in pancreatic cancer by sustaining a constitutive activation of nuclear factor-kappaBWhy not treat human cancer with interleukin-1 blockade?Isothiocyanate analogs targeting CD44 receptor as an effective strategy against colon cancerHypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxia.Notch, IL-1 and leptin crosstalk outcome (NILCO) is critical for leptin-induced proliferation, migration and VEGF/VEGFR-2 expression in breast cancer.Chronic inflammation and cancer: potential chemoprevention through nuclear factor kappa B and p53 mutual antagonismGenetic suppression of inflammation blocks the tumor-promoting effects of TGF-β in gastric tissue.Seminal plasma induces the expression of IL-1α in normal and neoplastic cervical cells via EP2/EGFR/PI3K/AKT pathway.Serum cytokine concentrations, flavonol intake and colorectal adenoma recurrence in the Polyp Prevention Trial.BRAF(V600E) melanoma cells secrete factors that activate stromal fibroblasts and enhance tumourigenicity.The interleukin-1 family: back to the futureIL-1α -889 C/T polymorphism and cancer susceptibility: a meta-analysisLeptin pro-angiogenic signature in breast cancer is linked to IL-1 signalling.A cytokine-mediated link between innate immunity, inflammation, and cancer.Inflammation, but not hypoxia, mediated HIF-1alpha activation depends on COX-2Role of Notch and its oncogenic signaling crosstalk in breast cancer.Dendritic cell IL-1α and IL-1β are polyubiquitinated and degraded by the proteasome.FSP1+ fibroblasts promote skin carcinogenesis by maintaining MCP-1-mediated macrophage infiltration and chronic inflammation.A systems biology analysis of metastatic melanoma using in-depth three-dimensional protein profiling.The effect of lung cancer on cytokine expression in peripheral blood mononuclear cellsAssociation of interleukin 1 beta (IL-1β) polymorphism with mRNA expression and risk of non small cell lung cancerInflammatory mediators in breast cancer: coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition
P2860
Q21143797-614AF858-4640-4FE6-A6BF-4161288C2F73Q26752817-533187E7-42F6-4ACF-9766-C9436AC17A01Q26861403-4E432A77-4189-4050-AA1D-2E59D9A2C24CQ26999689-90CFC3D6-92EF-4124-A220-111B7731A5D3Q27322202-773D5928-3FF3-448D-9017-FFDE03748D6DQ28077074-6052D6A2-A724-4785-BAFB-2CCCC1BBBDE1Q28269704-720270E5-B239-488A-BB88-A70C6A847244Q28384920-EF2C544A-70F2-4C50-906A-25948BF31B54Q28388199-90724375-D3B9-47B7-AB41-0435F687B394Q28485910-5428B6D2-196F-416C-B2EB-348EE51AB9FBQ28539655-86FD3F60-7390-4BE3-B28B-6B4B13919425Q30423875-74921586-59AF-4576-BF76-DFC502F5980EQ33526078-1FE1AF4E-6F02-42A4-A196-5C28C77E5849Q33592943-FCD2794E-3AB1-4006-8D2E-53F95215D238Q33706144-D7E6C964-730B-4B00-B5EF-17A863166CB6Q33725919-EABDECF2-E593-403C-8B96-08FB51172402Q33727960-940F3AA7-66F1-44D0-84EA-1974F6165AE7Q33798530-676C6597-FF9C-4557-BAF1-6EC7D107E1ABQ33799457-2CA9D5CB-4A9E-4FF1-959C-13E3A235B513Q33833871-C7F245E2-4E2A-4623-9CB8-046F2B96C14FQ33855839-A0D0ECB6-3790-4CB3-8C59-EC521B3EEFE2Q33899678-C71B206A-F5B1-4E59-A616-D7CFC7B66880Q33952473-053BEBD4-BF74-4B3C-99DD-400D49111378Q34079481-6A411673-7709-40F1-B923-8EE447403838Q34154062-12CC8D2C-DE53-4B6B-92E0-3A2269DAF5DFQ34199061-4D332C60-BA66-44B1-B9C0-C379D17794BAQ34344133-5F28DE50-A946-4CAE-A530-304F1356C911Q34354569-49045E92-24E2-4AC2-81F7-ED3031440E15Q34391415-D5DC96DC-21BC-4DD1-9A57-C19EE9F2EB0CQ34523165-D1B22DE2-6193-4E51-A067-4E686F4C1F68Q34577547-9354F48E-923D-4455-A82F-54D74F70660DQ34625152-7A711E12-C66B-4A11-9E67-751B00E380A1Q34683465-ACA2913A-465F-44AD-A178-4BB3A8B20107Q34697373-A546FFFA-41B4-415A-87CF-82165ED39443Q34738101-A2E29BC0-7242-4C74-BA8C-54CD2C8CB14CQ34760652-F859F0B3-099E-449F-8C91-28F4AD18F021Q34762291-FBB1BC30-B9E1-45EA-8204-5AB181247C3CQ34769405-5C2DEB0F-2D49-4FCF-BDA5-295FA0BE840FQ34878666-6CC7E6E8-1C77-411A-90F5-2F38ADCD8FDAQ34984217-0685A798-767F-4A6C-8D34-E937EE7BDFC1
P2860
The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The involvement of IL-1 in tum ...... s and tumor-host interactions.
@ast
The involvement of IL-1 in tum ...... s and tumor-host interactions.
@en
type
label
The involvement of IL-1 in tum ...... s and tumor-host interactions.
@ast
The involvement of IL-1 in tum ...... s and tumor-host interactions.
@en
prefLabel
The involvement of IL-1 in tum ...... s and tumor-host interactions.
@ast
The involvement of IL-1 in tum ...... s and tumor-host interactions.
@en
P2093
P2860
P1476
The involvement of IL-1 in tum ...... s and tumor-host interactions.
@en
P2093
Elena Voronov
Malka R White
Moshe Elkabets
Ron N Apte
Shahar Dotan
Tatyana Dvozkin
Xiaping Song
Yakov Krelin
Yaron Carmi
P2860
P2888
P304
P356
10.1007/S10555-006-9004-4
P577
2006-09-01T00:00:00Z